Atlas Venture Associates XII, L.P.

Track

Insider profile

Atlas Venture Associates XII, L.P.'s trades of Disc Medicine, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
403.79
Quantity 79,537
Value US$4,058,927
Transaction date
Proposed sale
Price
415.43
Quantity 55,909
Value US$1,691,378
Transaction date
Proposed sale
Price
167.80
Quantity 57,098
Value US$585,597
Transaction date
Proposed sale
Price
9.87
Quantity 131
Value US$1,293
Transaction date
Proposed sale
Price
11.50
Quantity 48
Value US$552
Transaction date
Proposed sale
Price
26.48
Quantity 11,882
Value US$314,635
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-16
PrS Proposed sale
79,537
403.79
US$4,058,927 		79,537 403.79 US$4,058,927
2025-12-15 2025-12-15
PrS Proposed sale
55,909
415.43
US$1,691,378 		55,909 415.43 US$1,691,378
2025-06-25 2025-06-25
PrS Proposed sale
57,098
167.80
US$585,597 		57,098 167.80 US$585,597
2025-06-24 2025-06-24
PrS Proposed sale
131
9.87
US$1,293 		131 9.87 US$1,293
2025-05-06 2025-05-06
PrS Proposed sale
48
11.50
US$552 		48 11.50 US$552
2024-04-09 2024-04-09
PrS Proposed sale
11,882
26.48
US$314,635 		11,882 26.48 US$314,635